Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Ioannis Papadimitriou

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomedicines|February 25, 2022
Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated FibrosisTheodoros-Ioannis Papadimitriou, Arjan van Caam, Peter M van der Kraan, et al.
Iscience|December 1, 2025
CD8+ T cells drive myofibroblast activation and contraction via JAK/STAT3 and TGFβ signalingTheodoros Ioannis Papadimitriou, Anne van Essen, Merel Willemse, et al.
Immunology|September 17, 2025
Mitochondrial Activity Regulates Human T Helper 17 Differentiation and FunctionXinlai Chen, Theodoros Ioannis Papadimitriou, Anne H G van Essen, et al.
Rheumatology (Oxford, England)|March 29, 2024
Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profileTheodoros Ioannis Papadimitriou, Jacqueline M J Lemmers, Arjan P M van Caam, et al.
Annals of the Rheumatic Diseases|December 20, 2023
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletionTheodoros Ioannis Papadimitriou, Prashant Singh, Arjan van Caam, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomedicines|February 25, 2022
Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated FibrosisTheodoros-Ioannis Papadimitriou, Arjan van Caam, Peter M van der Kraan, et al.
Iscience|December 1, 2025
CD8+ T cells drive myofibroblast activation and contraction via JAK/STAT3 and TGFβ signalingTheodoros Ioannis Papadimitriou, Anne van Essen, Merel Willemse, et al.
Immunology|September 17, 2025
Mitochondrial Activity Regulates Human T Helper 17 Differentiation and FunctionXinlai Chen, Theodoros Ioannis Papadimitriou, Anne H G van Essen, et al.
Rheumatology (Oxford, England)|March 29, 2024
Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profileTheodoros Ioannis Papadimitriou, Jacqueline M J Lemmers, Arjan P M van Caam, et al.
Annals of the Rheumatic Diseases|December 20, 2023
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletionTheodoros Ioannis Papadimitriou, Prashant Singh, Arjan van Caam, et al.
Pageof 1